why choose one-size-fits-all, when you can get the perfect loop for you?
Dexcom connects to the widest range of connected insulin pumps†,‡,1 so you can choose the right hybrid closed loop (HCL) system for you.
Big news! NICE now recommends HCL systems for people with Type 1 diabetes§,2,3
The National Institute for Health and Care Excellence (NICE) already recommends that all people living with Type 1 diabetes (T1D) are offered a choice of glucose sensor, including Dexcom real-time continuous glucose monitoring (CGM) systems.§,2
HCL systems are now also recommended for anyone with T1D who is:§,3
- Under 18 years old
- Over 18 with an elevated HbA1c of 7.5 or above
- Experiencing disabling hypoglycaemia
- Women who are pregnant or planning a pregnancy
- People already using an insulin pump
These new recommendations make Dexcom technology more accessible than ever before – so speak to your Healthcare Team about funding for a Dexcom CGM system§, then choose from the widest range of connected pumps†,‡,1 to create the perfect HCL system for you.
HCL systems explained…
Why choose a Dexcom powered HCL system?
Dexcom real-time CGM systems allow you to view your glucose levels at a glance,* to make informed decisions. When connected to one of a range of top brand insulin pumps,‡ they create an HCL system that automatically delivers your insulin dose as and when you need it.
Connect to an unparalleled choice of leading pumps†,‡,1
The Dexcom CGM system and connected insulin pump†,‡ constantly communicate with each other,|| sharing data and enable automatic insulin adjustments to help keep you in range – all without painful finger pricks,* multiple daily injections or scanning ever. And because Dexcom is the most connected CGM in the world,†,1 you have the freedom to choose the insulin pump that works best for you.
More choice
With an unparalleled choice of insulin pumps,†,‡,1 you can create an HCL system that works for you - so you’ll experience less of the highs and lows that can cause long and short-term complications.4,5 In fact, the more time people living with diabetes spend in their target range, the better and healthier they report feeling.6
Advanced protection
Dexcom has safely powered HCL systems for over 1 million patient-years of cumulative use.7 The in-built Urgent Low Soon Alert lets you know up to 20 minutes before you go low, and you can share data with up to 10 followers for added peace of mind.¶,#
Proven outcomes
Backed by over 30 studies,**,4 HCL systems powered by Dexcom real-time CGM have been proven to significantly increase Time in Range4,8,9 – helping you experience less of the highs and lows that can cause long and short-term complications.4
Don’t just take our word for it…
“Instead of having to wake up to prick our fingers every few hours, we were sleeping properly again, we had peace of mind. We saw how effective it was, how manageable things suddenly felt, and I knew instantly that this was the route forwards.”
Claire, Dexcom Warrior T1D, 28 years
The featured Warrior is a sponsored spokesperson of Dexcom
The featured Warrior is a sponsored spokesperson of Dexcom
Ready to take the next step?
Already a Dexcom user?
Not yet on Dexcom?
Those who are new to Dexcom and have diabetes (adults and children age two years and older) are eligible for a free sample. Please note, further eligibility criteria may apply.
Claire is a sponsored spokesperson of Dexcom.
* If your glucose alerts and readings from the Dexcom system do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† Dexcom G6 is the most connected CGM system available with over 60 connected partners worldwide. Not all Dexcom systems have the same connectivity.
Please check connectivity opat dexcom.com/en-gb/integrations-and-connectivity.
‡ Insulin pumps by Tandem, Insulet and Ypsomed.
§ Access to Dexcom real-time CGM systems can vary in different parts of the UK. Talk to your diabetes healthcare team to find out more about access and which product would work best for you.
|| Internet connectivity required for data sharing.
¶ Following requires an internet connection and the Dexcom Follow app.
# The Dexcom app including Urgent Low Soon Alert and Share and Follow functionality cannot be used with the MyLife App.
** Dexcom data also includes studies published later than inclusion criteria of the Peacock review (Peacock S, et al. Diabetes Ther. 2023;14(5):839–55).
* If your glucose alerts and readings from the Dexcom system do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† Dexcom G6 is the most connected CGM system available with over 60 connected partners worldwide. Not all Dexcom systems have the same connectivity.
Please check connectivity opat dexcom.com/en-gb/integrations-and-connectivity.
‡ Insulin pumps by Tandem, Insulet and Ypsomed.
§ Access to Dexcom real-time CGM systems can vary in different parts of the UK. Talk to your diabetes healthcare team to find out more about access and which product would work best for you.
|| Internet connectivity required for data sharing.
¶ Following requires an internet connection and the Dexcom Follow app.
# The Dexcom app including Urgent Low Soon Alert and Share and Follow functionality cannot be used with the MyLife App.
** Dexcom data also includes studies published later than inclusion criteria of the Peacock review (Peacock S, et al. Diabetes Ther. 2023;14(5):839–55).
1 Dexcom data on file, 2022.
2 Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. nice.org.uk/guidance/ng17.
3 National Institute for Health and Care Excellence https://www.nice.org.uk/guidance/gid-ta10845/documents/final-appraisal-determinationdocument.
4 Peacock S, et al. Diabetes Ther. 2023;14(5):839–55.
5 Brown SA, et al. Diabetes Care. 2021;44(7):1630–40.
6 Dexcom, UK data on file, July 2021.
7 Dexcom data on file, 2023.
8 Brown SA, et al. N Engl J Med. 2019;381(18):1707–17.
9 Breton MD, et al. 2020;383(9):836–45.
2 Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. nice.org.uk/guidance/ng17.
3 National Institute for Health and Care Excellence https://www.nice.org.uk/guidance/gid-ta10845/documents/final-appraisal-determinationdocument.
4 Peacock S, et al. Diabetes Ther. 2023;14(5):839–55.
5 Brown SA, et al. Diabetes Care. 2021;44(7):1630–40.
6 Dexcom, UK data on file, July 2021.
7 Dexcom data on file, 2023.
8 Brown SA, et al. N Engl J Med. 2019;381(18):1707–17.
9 Breton MD, et al. 2020;383(9):836–45.